September 24, 2015
Authored and Edited by Elizabeth D. Ferrill; Jeff T. Watson
In Summit 6, LLC v. Samsung Electronics Co., Nos. 13-1648, -1651 (Fed. Cir. Sept. 21, 2015), the Federal Circuit affirmed the district court’s denial of Samsung’s JMOL motion to exclude testimony from Summit 6’s expert, Paul Benoit. Benoit testified that Samsung would have agreed to pay $29 million to license a patent related to photo-sharing, while Samsung argued that the feature was not worth more than $1.5 million.
On appeal, Samsung argued that: (1) Benoit’s methodology was unpublished, created specifically for this litigation, and never before employed by Benoit or by another expert; (2) Benoit’s premise that a feature’s use is proportional to its value was incorrect; and (3) Benoit’s use of surveys was unreliable because he was not a survey expert.
While Daubert holds that a court may consider whether a methodology has been tested, published, or generally accepted, the Federal Circuit held that the admissibility inquiry is flexible and centers on whether the methodology is reliable and the data used is sufficiently tied to the facts of the case. The Court held that to the extent Benoit’s credibility, data, or factual assumptions have flaws, these flaws go to the weight of the evidence, not to its admissibility.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
At the PTAB Blog
May 20, 2026
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Federal Circuit IP Blog
Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay
May 14, 2026
Federal Circuit IP Blog
When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case
May 14, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.